Disclosure under Regulation 74 (5) of the SEBI (Depositories Participants) Regulations, 2018 for the quater ended June 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Adeshwar Meditex Ltd has submitted a routine compliance filing under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This regulation requires listed companies to furnish a certificate from their Registrar and Share Transfer Agent (RTA) confirming that all securities received for dematerialization during the quarter have been properly processed and credited. The filing covers the quarter ended June 30, 2025. No share counts, financial numbers, or specific transactions are disclosed in this particular update. This is a standard procedural submission made every quarter by virtually every listed company in India.
This is a routine regulatory compliance filing with no material impact on the stock price, business operations, or shareholder value. Retail investors can safely ignore this as it simply confirms the smooth functioning of share dematerialization processes.